Literature DB >> 7920697

Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity.

R B Kim1, D O'Shea, G R Wilkinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7920697

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


× No keyword cloud information.
  7 in total

1.  Spectrofluorimetric assessment of chlorzoxazone and ibuprofen in pharmaceutical formulations by using Eu-tetracycline HCl optical sensor doped in sol-gel matrix.

Authors:  M S Attia; M N Ramsis; L H Khalil; S G Hashem
Journal:  J Fluoresc       Date:  2011-11-09       Impact factor: 2.217

Review 2.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 3.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  M T Kinirons; P Crome
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

4.  Quantifying heterogeneity in exposure-risk relationships using exhaled breath biomarkers for 1,3-butadiene exposures.

Authors:  Thomas J Smith; Frederic Y Bois; Yu-Sheng Lin; Celine Brochot; Sandrine Micallef; David Kim; Karl T Kelsey
Journal:  J Breath Res       Date:  2008-09-08       Impact factor: 3.262

5.  RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

Authors:  J M Ladero; J A Agúndez; A Rodríguez-Lescure; M Diaz-Rubio; J Benítez
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

Review 6.  Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.

Authors:  A Hirvonen
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

7.  Role of cytochrome P450 in drug interactions.

Authors:  Zakia Bibi
Journal:  Nutr Metab (Lond)       Date:  2008-10-18       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.